Ignite Creation Date:
2025-12-24 @ 11:15 PM
Ignite Modification Date:
2025-12-25 @ 8:52 PM
Study NCT ID:
NCT07281456
Status:
RECRUITING
Last Update Posted:
2025-12-23
First Post:
2025-12-12
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren Disease
Sponsor:
National Institute of Dental and Craniofacial Research (NIDCR)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-12-18
Start Date Type:
ACTUAL
Primary Completion Date:
2030-12-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-12-15
Completion Date Type:
ESTIMATED
First Submit Date:
2025-12-12
First Submit QC Date:
None
Study First Post Date:
2025-12-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-20
Last Update Post Date:
2025-12-23
Last Update Post Date Type:
ESTIMATED